Mycophenolate mofetil Completed Phase 2 Trials for Transplantation, Kidney / Immunosuppression / Chronic Renal Failure (CRF) Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT00240994Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients